Cardiovascular manifestation in COVID-19 infection in a patient with rheumatoid arthritis: case report
DOI:
https://doi.org/10.33448/rsd-v10i14.22277Keywords:
Seniors; Cardiovascular diseases; COVID-19.Abstract
This study aimed to report the case of a 65-year-old female patient with a previous diagnosis of rheumatoid arthritis, among other comorbidities that corroborate the increase in cardiovascular risk, seen in 2020 in a private hospital in Belém, due to picture of acute coronary syndrome associated with SARS-Cov-2 virus infection. Due to the clinical profile, the patient underwent an electrocardiogram that showed myocardial infarction with ST-segment elevation alteration, indicating the need for reperfusion therapy, oxygen therapy and monitoring of vital signs. A chest CT scan showed a “ground glass” pattern and involvement of more than 25% of the lung parenchyma and evolved with thrombosis of the femoral artery. After treatment in the intensive care unit, he was discharged from the health service, remaining stable from a rheumatological, cardiovascular and pulmonary point of view.
References
Aviña-Zubieta, J. A., Abrahamowicz, M., De Vera, M. A., Choi, H. K., Sayre, E. C., Rahman, M. M., Sylvestre, M. P., Wynant, W., Esdaile, J. M., Lacaille, D. (2013). Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology. 52(1):68-75. Doi:10.1093/rheumatology/kes353.
Bergström, L. T., Turesson, J. C. (2009). Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long‐standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden. Rheumatology. 48:1600-5.
Bichile, T., Petri, M. (2014). Prevention and management of comorbidities in SLE. Presse Med. 43(6):187-95. Doi:10.1016/j.lpm.2014.03.009.
Burner, T. W., Rosenthal, A. K. (2009). Diabetes and rheumatic diseases. Curr Opin Rheumatol. 21(1):50-4. Doi: 10.1097/BOR.0b013e32831bc0c4.
Coronavirus Disease (COVID-19) – World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Coronavirus Disease 2019. Centers for Disease Control and Prevention, 25 de junho de 2020, https://www.cdc.gov/media/releases/2020/p0625-update-expands-covid-19.html.
Costa, I. B. S. S., Bittar, C. S., Rizk, S. T., Araújo Filho, A. E., Santos, K. A. Q., Machado, T. I. V., Andrade, F. T. A., González, T. B., Arévalo, A. N. G., Almeida, J. P., Bacal, F., Oliveira, G. M. M., Lacerda, M. V. G., Barberato, S. H., Chagas, A. C. P. (2020). O Coração e a COVID-19: O que o Cardiologista Precisa Saber. Arquivos Brasileiros de Cardiologia. 114(5):805-16. Doi:10.36660/abc.20200279.
Definição de Caso e Notificação. https://coronavirus.saude.gov.br/definicao-de-caso-e-notificacao. Acesso em: 4 de fevereiro de 2021.
Fernández, A. C., Izquierdo, A., Subirana, I., Farré, N., Vila, J., Durán, X., Guimaraes, M. G., Valdivielso, S., Cabero, P., Soler, C., Ribas, C. G., Rodríguez, C., Llagostera, M., Mojón, D., Vicente, M., González, E. S., Carpintero, A. S., Tevar, C., Marrugat, J., Vaquerizoa, B. (2020).
Gabriel, S. E., Cynthia, S. (2012). Crowson. Risk Factors for Cardiovascular Disease in Rheumatoid Arthritis. Current Opinion in Rheumatology. 24(2):171-6. Doi:10.1097/BOR.0b013e32834ff2fd.
Gomes, A. A. Estudo de caso - planejamento e métodos. Nuances: estudos sobre Educação. Presidente Prudente, SP, ano XIV, v. 15, n. 16, p. 215-221, jan./dez. 2008.
Figueiredo Neto, J. A., Braga, F. G. M., Moura, L. Z., Figueiredo, M. A. S., Figueiredo, V. M. S., Rocha, R. M., Mesquita, E. T. Doença de Coronavírus-19 e o Miocárdio. Arquivos Brasileiros de Cardiologia. 114(6):1051-57. Doi:10.36660/abc.20200373.
Filippini, F. B., Silva, R. L., Vieira, R. G., Fattah, T., Joaquim, R. M. (2020). Infarto agudo do miocárdio tipo 2 induzido por COVID-19 em paciente com doença arterial coronariana grave desconhecida. J Transcat Intervent, 28(9). Doi:10.31160/JOTCI202028A20200022.
Folha informativa COVID-19 - Escritório da OPAS e da OMS no Brasil - OPAS/OMS. Organização Pan-Americana da Saúde. https://www.paho.org/pt/covid19.
Hannawi, S., Haluska, B., Marwick, T. H., Thomas, R. (2007). Atherosclerotic Disease Is Increased in Recent-Onset Rheumatoid Arthritis: A Critical Role for Inflammation. Arthritis Research & Therapy. 9(6):116. Doi:10.1186/ar2323.
Hannawi, S., Hannawi, H., Alokaily, F., Naredo, E., Moller, I., Salmi, I. A. (2018). Recent-Onset of Rheumatoid Arthritis Leads to Increase in Wall Thickness of Left Anterior Descending Coronary Artery. An Evidence of Subclinical Coronary Artery Disease. Saudi Medical Journal. 39;(12):1213-17. Doi:10.15537/smj.2018.12.23185.
Hannawi, S., Marwick, T. H., Thomas, R. (2009). Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Research & Therapy. 11(2):51. Doi:10.1186/ar2668.
Lazaros, G., Dimitrios, T. (2015). Rheumatoid Arthritis and Atherosclerosis: Could Common Pathogenesis Translate Into Common Therapies?. Hellenic J Cardiol., 56(5):414-7. https://pubmed.ncbi.nlm.nih.gov/26429370/.
Markers of myocardial injury in the prediction of short-term COVID-19 prognosis. Revista Espanola De Cardiologia. 5:811-818. PubMed, doi:10.1016/j.recesp.2020.09.017.
McInnes, I. B., Scheet, G. (2011). The Pathogenesis of rheumatoid arthritis. N Engl J Med. 365;(2):2205-19.
Mikuls, T. D., Johnson, S. R., Gravallese, E. M., Saag, K. G. (2020). Coronavirus disease 2019 (COVID-19): Care of patients with systemic rheumatic disease during the pandemic. 29 Mai 29 2020 [citado em 05 Jun 2020]. In: UpToDate [Internet]. 2020. Disponível em: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-care-of-patients-with-systemic-rheumatic-disease-during-the-pandemic.
Mikuls, T. R. (2003). Comorbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 17(5):729-52. Doi: 10.1016/s1521-6942(03)00041-x.
Mikuls, T. R., Johnson, S. R., Fraenkel, L., Arasaratnam, R. J., Baden, L. R., Bermasm B. L., Chatham, W., Cohen, S., Costenbader, K., Gravallese, E. M., Kalil, A. C., Weinblatt, M. E., Winthrop, K., Mudano, A. S., Turner, A., Saag, K. G. (2020). American college of rheumatology guidance for the management of rheumatic disease in adult patients during the covid-19 pandemic: version 1. Arthritis & Rheumatology. 2(0):1-11.
Nurmohamed, M. T., Heslinga, M., Kitas, G. D. (2015). Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 11:693-704.
Prasad, M., Hermann, J., Gabriel, S. E., Weyand, C. M., Mulvagh, S., Mankad, R., Oh, J. K., Matteson, E. L., Lerman, A. Cardiorheumatology: Cardiac Involvement in Systemic Rheumatic Disease. Nature Reviews Cardiology. 12(3):168-76. Doi:10.1038/nrcardio.2014.206.
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 323(20):2052-2059.
Sarkisian, L. (2016). Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac Conditions. The American Journal of Medicine. 129(5):506-514. Doi:10.1016/j.amjmed.2015.12.009.
Singer, M., Bulled, N., Ostrach, B., Mendenhall, E. (2017). Syndemics and the biosocial conception of health. Lancet. 389;(4):941-950. Doi: 10.1016/S0140-6736(17)30003-X.
Solomon, D. H., Kremer, J., Curtis, J. R., Hochberg, M. C., Reed, G., Tsao, P., Farkouh, M. E., Setoguchi, S., Greenberg, J. D. (2010). Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 69:1920-5.
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 180(7):934-943. Disponível em: https://www.doi.org/10.1001/jamainternmed.2020.0994.
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., Zhou, Y. (2020). Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta‐analysis. Int J Infect Dis. 94:91-5.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., Cao, B. (2020). Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 395(2):1054-62.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med.; 382:727-33.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nina Pinto Monteiro Rocha; Natasha Valente dos Santos; Rodrigo Almeida Souza; Ivy de Almeida Cavalcante e Silva; André Maia de Oliveira Oliveira ; Daniel Dias Pinheiro de Moraes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
